Search

everythinglearnresearchcommunity

for

Search:↓

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

Female hair loss patients more likely to have dry eye and gland issues.

Androgenic alopecia is linked to more severe COVID-19 and higher mortality.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Testosterone increases hair growth and acne in transgender men.

New treatments for excessive hair growth in women, including advanced drugs and nanotechnology, show promise for better results.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

People with androgenetic alopecia are more likely to have metabolic syndrome.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

More men than women have hair loss, it's often inherited, and it's linked with higher testosterone levels. There's been a rise in female hair loss patients.

A rare adrenal tumor in a 14-year-old girl caused male-like symptoms and was successfully removed.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

Five new mutations in the androgen receptor gene were found, helping to understand androgen insensitivity syndrome better.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

Hormonal imbalances, especially high androgen levels and insulin resistance, are linked to worse acne in adult women.

Obesity is strongly linked to the severity of hirsutism in women.

Targeting androgen receptors with antiandrogen oligonucleotides could effectively treat hair loss.

People with early hair loss may have higher insulin levels and a greater chance of developing metabolic syndrome.

Men with early onset hair loss are more likely to have high uric acid levels.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

Large prostate patients more likely to have hair loss.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.